CPT1A and polycystic ovary syndrome: As seen in Fig. 8A–C, in SAT, PCOS rats had decreased CPT1A mRNA expression compared to controls (− 2.36 ± 0.57 vs 0.00 ± 0.11, P < 0.0001) with no significant change in CPT1B or MCAD mRNA expression.